＜5253＞ Cover 1527 -210 ＜6613＞ QD Laser 365 -12 Fallen. After the end of trading on the 8th, the performance of the first quarter of the 25-year fiscal year was announced and sold. Revenue was 22.6 billion yen (11.6% decrease year-on-year). Due to the reconstruction of sales channels for visual information device business, sales and general administration expenses still exceeded gross profit and operating loss was 1.67 billion yen (compared to a loss of 1.26 billion yen in the same period of the previous year), and the loss widened. Each stage loss has increased from the same period of the previous year, but it is progressing as planned for the current year's estimate. ＜7094＞ NexTone 1600 +300 ＜2173＞ Hakuten 505 +80 This is a limit-up. The performance of the second quarter (interim period) of the 24 fiscal year is well received. Sales were 10.069 billion yen. In addition, sales gross profit was 2.985 billion yen, Operating profit was 1.008 billion, ordinary profit was 1 billion yen, and net profit for the parent company's shareholders for the interim period was 680 million yen, which exceeded the forecast announced in February due to a significant increase in sales mainly due to deepening existing customers. Sales revenue for real event field was 8.268 billion yen, sales revenue for digital field was 0.504 billion yen, and sales revenue for business environment field was 1.134 billion yen, and it is steadily growing. ＜4570＞ Immuno-Biological Laboratories 461 +37 ＜2370＞ MDNT 45 +3

Significantly declined. After the close of trading on the 8th, the performance for the first quarter of the 25th fiscal year ending in March was announced, with selling pressure becoming predominant. Revenue was 6.416 billion yen (+24.8% YoY), and operating profit was 0.834 billion yen (-6.8% YoY). Although the distribution/content sector has been performing well, it seems that it did not meet investors' expectations. The company is promoting the improvement of overall business profitability, while at the same time advancing the strengthening of content production capabilities and the establishment of a framework for future business expansion such as the recruitment of high-level personnel in its revenue division.

＜5253＞ Cover 1527 -210 ＜6613＞ QD Laser 365 -12 Fallen. After the end of trading on the 8th, the performance of the first quarter of the 25-year fiscal year was announced and sold. Revenue was 22.6 billion yen (11.6% decrease year-on-year). Due to the reconstruction of sales channels for visual information device business, sales and general administration expenses still exceeded gross profit and operating loss was 1.67 billion yen (compared to a loss of 1.26 billion yen in the same period of the previous year), and the loss widened. Each stage loss has increased from the same period of the previous year, but it is progressing as planned for the current year's estimate. ＜7094＞ NexTone 1600 +300 ＜2173＞ Hakuten 505 +80 This is a limit-up. The performance of the second quarter (interim period) of the 24 fiscal year is well received. Sales were 10.069 billion yen. In addition, sales gross profit was 2.985 billion yen, Operating profit was 1.008 billion, ordinary profit was 1 billion yen, and net profit for the parent company's shareholders for the interim period was 680 million yen, which exceeded the forecast announced in February due to a significant increase in sales mainly due to deepening existing customers. Sales revenue for real event field was 8.268 billion yen, sales revenue for digital field was 0.504 billion yen, and sales revenue for business environment field was 1.134 billion yen, and it is steadily growing. ＜4570＞ Immuno-Biological Laboratories 461 +37 ＜2370＞ MDNT 45 +3

The price fell. After the close of trading on the 8th, the performance of the first quarter of the 25-year fiscal year was announced and sold, and as a result, the price fell. Revenue was 22.6 billion yen (11.6% decrease year-on-year). Due to the reconstruction of sales channels for visual information device business, sales and general administration expenses still exceeded gross profit and operating loss was 1.67 billion yen (compared to a loss of 1.26 billion yen in the same period of the previous year), and the loss widened. Each stage loss has increased from the same period of the previous year, but it is progressing as planned for the current year's estimate.

＜5253＞ Cover 1527 -210 ＜6613＞ QD Laser 365 -12 Fallen. After the end of trading on the 8th, the performance of the first quarter of the 25-year fiscal year was announced and sold. Revenue was 22.6 billion yen (11.6% decrease year-on-year). Due to the reconstruction of sales channels for visual information device business, sales and general administration expenses still exceeded gross profit and operating loss was 1.67 billion yen (compared to a loss of 1.26 billion yen in the same period of the previous year), and the loss widened. Each stage loss has increased from the same period of the previous year, but it is progressing as planned for the current year's estimate. ＜7094＞ NexTone 1600 +300 ＜2173＞ Hakuten 505 +80 This is a limit-up. The performance of the second quarter (interim period) of the 24 fiscal year is well received. Sales were 10.069 billion yen. In addition, sales gross profit was 2.985 billion yen, Operating profit was 1.008 billion, ordinary profit was 1 billion yen, and net profit for the parent company's shareholders for the interim period was 680 million yen, which exceeded the forecast announced in February due to a significant increase in sales mainly due to deepening existing customers. Sales revenue for real event field was 8.268 billion yen, sales revenue for digital field was 0.504 billion yen, and sales revenue for business environment field was 1.134 billion yen, and it is steadily growing. ＜4570＞ Immuno-Biological Laboratories 461 +37 ＜2370＞ MDNT 45 +3

The stock price has hit the daily limit increase. After the close of trading on the 8th, the first quarter of the 2025 fiscal year performance was announced, which was well received by investors. Due to the expansion of scale resulting from the consolidation of RecoChoku Group, revenue increased significantly to 4.819 billion yen (an increase of 215.7% from the same period last year), and despite continuing to make lead investments in growth areas and new businesses within RecoChoku Group, operating profit increased to 0.225 billion yen (an increase of 104.9%), ordinary profit was 0.242 billion yen (an increase of 112.4%), and quarterly net profit attributable to parent company shareholders was 0.165 billion yen (an increase of 113.2%).

＜5253＞ Cover 1527 -210 ＜6613＞ QD Laser 365 -12 Fallen. After the end of trading on the 8th, the performance of the first quarter of the 25-year fiscal year was announced and sold. Revenue was 22.6 billion yen (11.6% decrease year-on-year). Due to the reconstruction of sales channels for visual information device business, sales and general administration expenses still exceeded gross profit and operating loss was 1.67 billion yen (compared to a loss of 1.26 billion yen in the same period of the previous year), and the loss widened. Each stage loss has increased from the same period of the previous year, but it is progressing as planned for the current year's estimate. ＜7094＞ NexTone 1600 +300 ＜2173＞ Hakuten 505 +80 This is a limit-up. The performance of the second quarter (interim period) of the 24 fiscal year is well received. Sales were 10.069 billion yen. In addition, sales gross profit was 2.985 billion yen, Operating profit was 1.008 billion, ordinary profit was 1 billion yen, and net profit for the parent company's shareholders for the interim period was 680 million yen, which exceeded the forecast announced in February due to a significant increase in sales mainly due to deepening existing customers. Sales revenue for real event field was 8.268 billion yen, sales revenue for digital field was 0.504 billion yen, and sales revenue for business environment field was 1.134 billion yen, and it is steadily growing. ＜4570＞ Immuno-Biological Laboratories 461 +37 ＜2370＞ MDNT 45 +3

＜5253＞ Cover 1527 -210 ＜6613＞ QD Laser 365 -12 Fallen. After the end of trading on the 8th, the performance of the first quarter of the 25-year fiscal year was announced and sold. Revenue was 22.6 billion yen (11.6% decrease year-on-year). Due to the reconstruction of sales channels for visual information device business, sales and general administration expenses still exceeded gross profit and operating loss was 1.67 billion yen (compared to a loss of 1.26 billion yen in the same period of the previous year), and the loss widened. Each stage loss has increased from the same period of the previous year, but it is progressing as planned for the current year's estimate. ＜7094＞ NexTone 1600 +300 ＜2173＞ Hakuten 505 +80 This is a limit-up. The performance of the second quarter (interim period) of the 24 fiscal year is well received. Sales were 10.069 billion yen. In addition, sales gross profit was 2.985 billion yen, Operating profit was 1.008 billion, ordinary profit was 1 billion yen, and net profit for the parent company's shareholders for the interim period was 680 million yen, which exceeded the forecast announced in February due to a significant increase in sales mainly due to deepening existing customers. Sales revenue for real event field was 8.268 billion yen, sales revenue for digital field was 0.504 billion yen, and sales revenue for business environment field was 1.134 billion yen, and it is steadily growing.

＜5253＞ Cover 1527 -210 ＜6613＞ QD Laser 365 -12 Fallen. After the end of trading on the 8th, the performance of the first quarter of the 25-year fiscal year was announced and sold. Revenue was 22.6 billion yen (11.6% decrease year-on-year). Due to the reconstruction of sales channels for visual information device business, sales and general administration expenses still exceeded gross profit and operating loss was 1.67 billion yen (compared to a loss of 1.26 billion yen in the same period of the previous year), and the loss widened. Each stage loss has increased from the same period of the previous year, but it is progressing as planned for the current year's estimate. ＜7094＞ NexTone 1600 +300 ＜2173＞ Hakuten 505 +80 This is a limit-up. The performance of the second quarter (interim period) of the 24 fiscal year is well received. Sales were 10.069 billion yen. In addition, sales gross profit was 2.985 billion yen, Operating profit was 1.008 billion, ordinary profit was 1 billion yen, and net profit for the parent company's shareholders for the interim period was 680 million yen, which exceeded the forecast announced in February due to a significant increase in sales mainly due to deepening existing customers. Sales revenue for real event field was 8.268 billion yen, sales revenue for digital field was 0.504 billion yen, and sales revenue for business environment field was 1.134 billion yen, and it is steadily growing. ＜4570＞ Immuno-Biological Laboratories 461 +37 ＜2370＞ MDNT 45 +3

Continued gain. Net sales for the first quarter ending March 25th were ¥0.229 billion, an increase of 29.6% from the same period last year. Operating income was ¥0.051 billion due to the increase in net sales. Ordinary income was ¥0.056 billion, up 318.5% due to the effects of foreign exchange gains. The quarterly net loss attributable to parent company shareholders was ¥0.051 billion, an increase of 359.9% due to adjustments for corporate taxes. The progress rate for the earnings forecast is high, but the previous forecast was maintained as sales that had been anticipated for the second quarter and beyond were brought forward to account for sales in the current period.

＜5253＞ Cover 1527 -210 ＜6613＞ QD Laser 365 -12 Fallen. After the end of trading on the 8th, the performance of the first quarter of the 25-year fiscal year was announced and sold. Revenue was 22.6 billion yen (11.6% decrease year-on-year). Due to the reconstruction of sales channels for visual information device business, sales and general administration expenses still exceeded gross profit and operating loss was 1.67 billion yen (compared to a loss of 1.26 billion yen in the same period of the previous year), and the loss widened. Each stage loss has increased from the same period of the previous year, but it is progressing as planned for the current year's estimate. ＜7094＞ NexTone 1600 +300 ＜2173＞ Hakuten 505 +80 This is a limit-up. The performance of the second quarter (interim period) of the 24 fiscal year is well received. Sales were 10.069 billion yen. In addition, sales gross profit was 2.985 billion yen, Operating profit was 1.008 billion, ordinary profit was 1 billion yen, and net profit for the parent company's shareholders for the interim period was 680 million yen, which exceeded the forecast announced in February due to a significant increase in sales mainly due to deepening existing customers. Sales revenue for real event field was 8.268 billion yen, sales revenue for digital field was 0.504 billion yen, and sales revenue for business environment field was 1.134 billion yen, and it is steadily growing. ＜4570＞ Immuno-Biological Laboratories 461 +37 ＜2370＞ MDNT 45 +3

Announced the start of manufacturing special cell processed products used for the treatment of male and female pattern baldness using cultivated in-house hair follicle sheath cells. In recent years, research on hair regeneration for the purpose of treating baldness has advanced, but the scalp is administered with DSC cells, which are believed to be essential to the growth of hair follicles and are located beneath the hair germinal matrix cells, by cultivating hair germinal sheath (DSC) cells named "S-DSC." Results have shown the potential for promoting hair growth. Shiseido Company, Limited Sponsored ADR supplies the technology and oversees production processes at its manufacturing facilities.